Copanlisib: First Global Approval
Year: 2017
Type: article
Source: Drugs
Author: Anthony Markham
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: copanlisib, PI3K inhibitors, relapsed follicular lymphoma, accelerated approval, diffuse large B-cell lymphoma, peripheral T-cell lymphoma, NK/T-cell lymphoma, cholangiocarcinoma, breast cancer, head and neck squamous cell carcinoma, PTEN loss, PIK3CA mutation, drug development, FDA approval
Open Access status: closed
OpenAlex ID: W2767661899
